Arrowhead Research | GJELD



Debt Endring Dato
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
Incyte USD 37.96M 5.81M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Ligand Pharmaceuticals USD 24K 0 2024-12
Merck USD 37.11B 1.02B 2024-12
Moderna USD 62M 593M 2024-12
Novartis USD 31.26B 828M 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
TG Therapeutics USD 244.43M 271K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 163.61M 145.69M 2024-12



Arrowhead Research GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.